Back to search

France· FR:68173560

MICROPAKINE L.P. 100 mg, granulés à libération prolongée en sachet-dose

A medicinal product containing valproate de sodium + acide valproïque, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMICROPAKINE L.P. 100 mg, granulés à l…ATC—REGISTER NO.FR:68173560PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VALPROATE DE SODIUM + ACIDE VALPROÏQUE
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936551152
    30 sachet(s)-dose(s) papier aluminium complexe résine(s) ionomère
    EUR 3.04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Valproate de sodium + acide valproïque in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valproate de sodium + acide valproïque products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Convulex
  • Bulgaria · Convulex, Конвулекс
  • Czechia · Convulex
  • Germany · Convulex
  • Estonia · Convulex
  • United Kingdom (Northern Ireland) · Convulex
  • Hungary · Convulex
  • Lithuania · Convulex
  • Latvia · Convulex
  • Poland · Convulex, Convulex 150
  • Portugal · Ácido Valpróico Generis
  • Romania · Convulex
  • Slovakia · Convulex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2da8071d-049d-4276-8a24-2ff280c74a88
GET /v1/drugs/2da8071d-049d-4276-8a24-2ff280c74a88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68173560",
  "date_amm": "2004-09-13",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "VALPROATE DE SODIUM + ACIDE VALPROÏQUE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "granulés à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about valproate de sodium + acide valproïque.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.